Company / Working Capital per Share
Outlook Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$1.19
FY2025
5-year range
-$1.19 / $0.07
FY2021-FY2025
Trend
-1755.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share changed -1755% YoY in FY2025, a notable deviation from the 5-year average annual change of -317%.
Based on SEC 10-K filings.
-1.19 in FY2025.
Declined from $-0.75 to $-1.19 over the past 6 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share decreased 1755.4% year-over-year.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.19 | -1755.4% |
| FY2020 | $0.07 | +109.6% |
| FY2019 | -$0.75 | +34.8% |
| FY2018 | -$1.15 | -5.8% |
| FY2017 | -$1.09 | +30.4% |
| FY2016 | -$1.56 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026